Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 20 Feb 2024

Exosomal miR-223-3p from bone marrow mesenchymal stem cells targets HDAC2 to downregulate STAT3 phosphorylation to alleviate HBx-induced ferroptosis in podocytes

in Renal Pharmacology

Yueqi Chen
Xiaoqian Yang
Moxuan Feng
Yani Yu
Yongzheng Hu
Wei Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1327149

3,887 views
17 citations

Original Research

Published on 19 Feb 2024

Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of SIRT1/Nrf2/NF-κB/TNF-α signaling pathways

in Renal Pharmacology

Sandy R. Botros
Asmaa I. Matouk
Amr Amin
Gehan H. Heeba

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1353029

3,975 views
19 citations

Original Research

Published on 14 Feb 2024

Comparison of the efficacy of steroid-free versus classic steroid-containing regimens in primary membranous nephropathy

in Renal Pharmacology

Hui-Lin Xing
Dong-Hong Ma
Jin Li
Qing-Yu Xu
Li-Ke Ji
Qiong-Jie Zhu
Yu-Qing Luo
Ming-Hao Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1286422

1,783 views
1 citation

Review

Published on 12 Feb 2024

Acute kidney injury: exploring endoplasmic reticulum stress-mediated cell death

in Renal Pharmacology

Cong Cheng
Yuan Yuan
Fang Yuan
Xin Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1308733

4,172 views
10 citations

Brief Research Report

Published on 05 Feb 2024

Mitophagy regulates mitochondrial number following pharmacological induction of mitochondrial biogenesis in renal proximal tubule cells

in Renal Pharmacology

Kevin A. Hurtado
Rick G. Schnellmann

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1344075

2,506 views
6 citations

Brief Research Report

Published on 01 Feb 2024

Determination of glomerular filtration rate “en passant” after high doses of iohexol for computed tomography in intensive care medicine—a proof of concept

in Renal Pharmacology

Alexander Dejaco
Christoph Dorn
Michael Paal
Michael Gruber
Bernhard M. Graf
Martin G. Kees

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1346343

2,138 views
1 citation

Original Research

Published on 23 Jan 2024

Unravelling the role of Sildenafil and SB204741 in suppressing fibrotic potential of peritoneal fibroblasts obtained from PD patients

in Renal Pharmacology

Saurabh Chaturvedi
Harshit Singh
Vikas Agarwal
Akhilesh Jaiswal
Narayan Prasad

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1279330

2,028 views
1 citation

Mini Review

Published on 22 Jan 2024

Ceftazidime-avibactam induced renal disorders: past and present

in Renal Pharmacology

Yanrong Shi
Jichao Wu
Wei Mi
Xusheng Zhang
Xiuli Ren
Chengwu Shen
Cuicui Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1329307

3,750 views
5 citations

Review

Published on 19 Jan 2024

Urinary biomarkers associated with podocyte injury in lupus nephritis

in Renal Pharmacology

Zhiying Guo
Qianyu Guo
Xiaochen Li
Xinnan Gao
Liyun Zhang
Ke Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1324540

3,920 views
5 citations

Original Research

Published on 19 Jan 2024

Kidney derived apolipoprotein M and its role in acute kidney injury

in Renal Pharmacology

Line S. Bisgaard
Pernille M. Christensen
Jeongah Oh
Federico Torta
Ernst-Martin Füchtbauer
Lars Bo Nielsen
Christina Christoffersen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1328259

2,521 views

Review

Published on 16 Jan 2024

The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis

in Renal Pharmacology

Na Ren
Wen-Feng Wang
Liang Zou
Yan-Long Zhao
Hua Miao
Ying-Yong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1335094

6,817 views
13 citations

Editorial

Published on 15 Jan 2024

Editorial: Transporters: a hitchhiker’s guide to physiology, toxicology, and pharmacology—TransportDays 2022

in Renal Pharmacology

Giuliano Ciarimboli
Rosalinde Masereeuw
Stefan Oswald

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1365106

1,138 views

Systematic Review

Published on 11 Jan 2024

Tumor risks of finerenone in patients with type 2 diabetes mellitus complicated with chronic kidney disease: a meta-analysis and systematic review of randomized controlled trials

in Renal Pharmacology

Yue Du
Gui Cao
Linlin Gu
Yuehong Chen
Jingyu Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1237583

2,650 views
4 citations

Original Research

Published on 09 Jan 2024

Using real-world data to inform dosing strategies of rituximab for pediatric patients with frequent-relapsing or steroid-dependent nephrotic syndrome: a prospective pharmacokinetic-pharmacodynamic study

in Renal Pharmacology

Yewei Chen
Qian Shen
Ye Xiong
Min Dong
Hong Xu
Zhiping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1319744

2,212 views

Editorial

Published on 09 Jan 2024

Editorial: Global excellence in renal pharmacology 2022: Central and South America

in Renal Pharmacology

Vinicius Andrade-Oliveira
Orestes Foresto-Neto
Niels Olsen Saraiva Câmara

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1362010

977 views

Review

Published on 08 Jan 2024

Pharmacological functions of salidroside in renal diseases: facts and perspectives

in Renal Pharmacology

Qiong Liu
Jianzhu Chen
Anqi Zeng
Linjiang Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1309598

21,638 views
14 citations